Technische Universitat Dresden

Site:	Technische Universitat Dresden
Address:
City:	Dresden
State:
Zip:
Country:	Germany

Phase	Trial	Trial Status	Site Status	Drug [asc]	NCT#
3	A Study of DCC-2618 vs Sunitinib in Advanced GIST Patients After Treatment With Imatinib (intrigue)	Active, not recruiting	Active	QINLOCK Ripretinib DCC-2618 SUTENT Sunitinib	NCT03673501